D3 Bio completes Series A+ financing round led by Medicxi with US$62M to advance pioneering oncology pipeline
Amount Raised
$62 Million
Round Type
Series A
Investors
Description
D3 Bio closed the Series A+ financing round with a substantial investment of US$62M led by Medicxi, with participation from existing investors. The funding will be allocated to expedite the development of D3 Bio's assets through preclinical and clinical stages, with a particular focus on accelerating the global clinical trial of D3S-001, a new generation small molecule KRAS G12C inhibitor.
Quick answer
D3 Bio raised $62 Million in a Series A round, dated April 8, 2024. Investors: Wu Xi App Tec's Corporate Venture Fund, Matrix Partners China and Medicxi.
- How much did D3 Bio raise?
- D3 Bio raised $62 Million in a Series A round on April 8, 2024.
- Who invested in D3 Bio?
- Wu Xi App Tec's Corporate Venture Fund, Matrix Partners China and Medicxi are named as investors in this round.
- What does D3 Bio do?
- D3 Bio is a globally orientated, clinical stage biotechnology company that focuses on the discovery, development, and registration of new medicines in oncology and immunology.
- Who are the decision-makers at D3 Bio?
- Fundz holds 2 contacts at D3 Bio, including the Co-Founder & Cfo/cbo. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as D3 Bio that raised within 45 days of this round, from Fundz verified event records.
- Bicycle Therapeutics raised $555M (Post-IPO Equity) on May 23, 2024.
- Grey Wolf Therapeutics raised $50M (Series B) on May 23, 2024.
- Pheon Therapeutics raised $120M (Series B) on May 21, 2024.
- YGION Biomedical raised $16M (Series A) on May 21, 2024.
- Limula raised $6.8M (Seed) on May 21, 2024.
- AltruBio Inc. raised $225M (Series B) on May 21, 2024.
Who to call at D3 Bio, and when
A new round usually means D3 Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day D3 Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at D3 Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at D3 Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment D3 Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansD3 Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.